Carsten Rose
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 44
- Cancer Genomics and Diagnostics 7
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 32
- HER2/EGFR in Cancer Research 18
- Cancer Risks and Factors 7
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 14
- Radiation top 1%
- Otorhinolaryngology top 2%
-
- Estrogen and related hormone effects 37
-
- Cell Adhesion Molecules Research 7
Carsten Rose
114 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 4.6k
- Oncology 3.1k
- Pathology and Forensic Medicine 2.0k
- Radiation 555
- Otorhinolaryngology 171
Countries citing papers authored by Carsten Rose
This map shows the geographic impact of Carsten Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Rose more than expected).
Fields of papers citing papers by Carsten Rose
This network shows the impact of papers produced by Carsten Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Rose. The network helps show where Carsten Rose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carsten Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 1 | |
| 2 | 2006 | 12 | |
| 3 | 2003 | 18 | |
| 4 | 2000 | 16 | |
| 5 | 2000 | 69 | |
| 6 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialbreakdown → | 1999 | 1203 |
| 7 | 1999 | 22 | |
| 8 | 1998 | 88 | |
| 9 | Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2. | 1998 | 14 |
| 10 | 1997 | 9 | |
| 11 | 1996 | 6 | |
| 12 | 1996 | 1 | |
| 13 | 1995 | 34 | |
| 14 | 1994 | 39 | |
| 15 | 1993 | 141 | |
| 16 | 1992 | 47 | |
| 17 | 1991 | 38 | |
| 18 | 1990 | 58 | |
| 19 | 1988 | 31 | |
| 20 | 1988 | 14 |
About Carsten Rose
Carsten Rose is a scholar working on Cancer Research, Oncology and Genetics, having authored 115 papers that have together received 7.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (44 papers), Estrogen and related hormone effects (37 papers), Cancer Treatment and Pharmacology (32 papers), HER2/EGFR in Cancer Research (18 papers), Breast Lesions and Carcinomas (14 papers), Cancer Risks and Factors (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Cancer Research (4.6k citations), Oncology (3.1k citations) and Pathology and Forensic Medicine (2.0k citations). Carsten Rose has collaborated with scholars based in Denmark, Sweden and Germany. Frequent co-authors include Henning T. Mouridsen, Marie Overgaard, Jens Overgaard, Michael Kjær, C. Gadeberg, Maj‐Britt Jensen, Per Syrak Hansen, Karin Zedeler, Birgitte Rasmussen and Michael Andersson. Their work appears in journals such as Acta Oncologica, European Journal of Cancer, British Journal of Cancer, Breast Cancer Research and Treatment and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.